Advanced glycation end products (AGEs) have a crucial role in the process of atherosclerosis, particularly in patients with chronic renal failure (CRF), which have a dual form of damage, namely an increased formation of serum AGEs and their reduced clearance [1, 2]. We previously observed that AGEs can react with the peritoneal matrix protein, giving a reason for the gradual loss of peritoneal membrane function observed in patients undergoing long-term peritoneal dialysis [3, 4].
Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure
RAGAZZI, EUGENIO;FRANCINI PESENTI, FRANCESCO;BONFANTE, LUCIANA;LAPOLLA, ANNUNZIATA
2016
Abstract
Advanced glycation end products (AGEs) have a crucial role in the process of atherosclerosis, particularly in patients with chronic renal failure (CRF), which have a dual form of damage, namely an increased formation of serum AGEs and their reduced clearance [1, 2]. We previously observed that AGEs can react with the peritoneal matrix protein, giving a reason for the gradual loss of peritoneal membrane function observed in patients undergoing long-term peritoneal dialysis [3, 4].
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
